Printer Friendly
The Free Library
19,122,083 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cephalon, Inc. Conference Call to Discuss the Proceedings at the FDA Advisory Committee - Research and Markets Offers a Brief of 'Cephalon, Inc.' Conference Call.


DUBLIN, Ireland -- The Cephalon, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CEPH) Corporate Conference Call took place on 23-Mar-06 6:00pm ET.

CEPH announced a disappointing result from the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 Advisory Meeting regarding SPARLON for treatment of ADHD Attention-Deficit/Hyperactivity Disorder (ADHD) Definition

Attention-deficit/hyperactivity disorder (ADHD) is a developmental disorder characterized by distractibility, hyperactivity, impulsive behaviors, and the inability to remain focused on tasks or
. 2006 EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format.  guidance remains at $3.80-4.00, while 2006 revenue guidance has been reduced to $1.45-1.50b.

More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/83475

This document provides a non-biased summary of the conference call detailing the key points and the full Q&A session.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 23, 2006
Words:92
Previous Article:Q2 2006 Solectron Earnings Conference Call - Research and Markets offers a brief of 'Solectron' Conference Call.
Next Article:Yahoo! Annual Meeting of Stockholders Thursday, May 25, 2006 at 10:00 AM PT/ 1:00 PM ET.
Topics:



Related Articles
Provigil looks promising for treatment of fatigue.
Immune-Based Therapies: FDA Meeting October 16.
Tenofovir: FDA Hearing October 3, Public Comment Deadlines September 26.
BIZWATCH\MARKETS.
Hepatitis C: FDA public meeting on peginterferon plus ribavirin, Nov. 14.
FDA may require more long-term data to approve psychiatric drugs.
Alkermes and Cephalon Receive FDA Approval of Vivitrol(TM) for the Treatment of Alcohol Dependence; First, Once-Monthly Injectable Medication...
GAO report criticizes FDA drug safety oversight.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles